News
Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?
CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
For Jill Skala, 49, a teacher in western Pennsylvania, the FDA's decision means that she will lose a more affordable option after her insurance drops Zepbound coverage on Jan. 1.
Taking any of the new weight loss drugs – like Zepbound, or a similar one called Wegovy – has required navigating many hurdles, from patchy insurance coverage to supply issues to out-of-pocket ...
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
For Jill Skala, 49, a teacher in western Pennsylvania, the FDA's decision means that she will lose a more affordable option after her insurance drops Zepbound coverage on Jan. 1.
As of July 1, CVS dropped Zepbound from preferred coverage for those covered by its pharmacy benefit manager, Caremark. Novo Nordisk A/S's Wegovy, a semiglutide injectable medicine, is now the ...
For Jill Skala, 49, a teacher in western Pennsylvania, the FDA's decision means that she will lose a more affordable option after her insurance drops Zepbound coverage on Jan. 1.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results